National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 285         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

   
Phase III

   
MRC-BR12
EU-20114, ISRCTN83176944, NCT00052455

 
 
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

   
Phase III

   
RTOG-0320
NCT00096265

 
 
A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases

   
Phase III

   
021108
NCT00124761

 
 
Radiation Therapy or Temozolomide in Treating Patients With Gliomas

   
Phase III

   
EORTC-22033
EORTC-26033, EudraCT-2004-002714-11, CAN-NCIC-CE5, NCT00182819, TROG 06.01, CE5

 
 
Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

   
Phase III

   
TASMC-05-FB-05235-CTIL
NCT00268684

 
 
Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

   
Phase III

   
RTOG-0525
EORTC-26052, EORTC-22053, NCT00304031

 
 
A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis

   
Phase III

   
JCOG0504
C000000307, NCT00280475

 
 
Comparing 2 Forms of Head Immobilization for Stereotactic Radiotherapy

   
Phase III

   
04U.534
NCT00328510

 
 
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

   
Phase III

   
NCCTG-N0574
N0574, ACOSOG-N0574, NCT00377156

 
 
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

   
Phase III

   
EF-11
NCT00379470

 
      1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov